Avian Pathogenic Escherichia coli (APEC) in Broilers: Virulence Genes, Serotyping, and Vaccine Development

Introduction

Avian pathogenic Escherichia coli (APEC) constitutes a major cause of colibacillosis in broiler chickens, leading to significant economic losses and welfare concerns in commercial poultry operations. APEC strains are a subset of extraintestinal pathogenic E. coli (ExPEC) that possess a distinct arsenal of virulence factors enabling colonization, invasion, and systemic dissemination within the avian host. The pathobiology of APEC infection involves respiratory tract entry, often following immunosuppressive events or environmental stress, followed by bacteremia and fibrinous polyserositis affecting the pericardium, air sacs, and liver [1, 2]. Understanding the genetic determinants of APEC pathogenicity, the distribution of serogroups, and the molecular epidemiology through techniques such as multilocus sequence typing (MLST) is critical for designing effective control measures. Vaccine development remains a cornerstone of sustainable APEC management, with autogenous bacterins and live-attenuated vaccines representing the two principal approaches evaluated in commercial flocks [3, 4]. This review synthesizes current knowledge on APEC virulence genes, serotyping, and vaccine strategies, with emphasis on the O78, O2, and O1 serogroups and the application of MLST for strain characterization.

Virulence Genes and Pathogenicity

APEC strains harbor a diverse repertoire of virulence-associated genes (VAGs) that distinguish them from commensal E. coli. These genes are often located on pathogenicity islands (PAIs), plasmids, or bacteriophage-associated genomic islands [5]. The major categories of APEC virulence factors include adhesins (e.g., type 1 fimbriae fimH, P fimbriae papC, and curli csgA), iron acquisition systems (e.g., aerobactin iucD, salmochelin iroN, and yersiniabactin fyuA), protectins (e.g., outer membrane protease ompT, increased serum survival iss), and toxins (e.g., hemolysin hlyF, vacuolating autotransporter toxin vat) [6, 7]. The iss gene, encoding a lipoprotein that confers resistance to complement-mediated killing, is strongly associated with APEC pathotype and is frequently used as a molecular marker for diagnostic screening [8].

Genomic characterization of extensively drug-resistant APEC strains has revealed the co-localization of virulence and antimicrobial resistance genes on mobile genetic elements, facilitating their co-transfer [3]. For example, a recent study characterized an extensively drug-resistant APEC strain carrying multiple plasmid-borne resistance determinants alongside the iroN, iucD, and iss virulence genes, underscoring the convergence of pathogenicity and resistance [3]. Similarly, clinical and non-clinical E. coli isolates from chickens exhibit overlapping virulence gene profiles, but APEC strains consistently show higher prevalence of iss, iroN, ompT, and hlyF [5]. The presence of temperate bacteriophages in APEC genomes further contributes to virulence gene dissemination, as demonstrated in Brazilian poultry isolates where prophage regions harbored genes encoding adhesins and toxins [10].

The biological mechanisms underlying APEC pathogenesis involve initial adhesion to respiratory epithelium via type 1 fimbriae, followed by invasion of air sac epithelial cells. Once systemic, APEC must evade host complement and phagocytosis, a function mediated by the iss gene product and the outer membrane protease OmpT, which degrades antimicrobial peptides [7]. Iron acquisition systems are essential for bacterial proliferation in the iron-limited environment of host tissues; the aerobactin siderophore system encoded by iucABCD is particularly critical for APEC virulence [6]. Recent work using artificial intelligence-identified antimicrobial peptides has demonstrated that targeting these iron acquisition pathways can effectively reduce APEC burden in broilers, highlighting the therapeutic potential of virulence-specific interventions [4].

Serotyping and Molecular Epidemiology

Serotyping based on O (lipopolysaccharide) and H (flagellar) antigens remains a primary method for classifying APEC isolates. Among broiler flocks, the O78, O2, and O1 serogroups are consistently reported as the most prevalent, accounting for a substantial proportion of colibacillosis cases worldwide [9, 12]. The O78 serogroup is particularly associated with severe systemic infections and has been the focus of numerous vaccine development efforts. In a study from Egypt, multidrug-resistant APEC strains from broilers predominantly belonged to O78 and O2 serogroups, and these isolates carried a high load of virulence genes including iss, iucD, and vat [12]. Similarly, fluoroquinolone-resistant APEC strains isolated from asymptomatic broilers in Thailand were predominantly O78 and O2, indicating that these serogroups can persist in carrier birds and serve as reservoirs for transmission [15].

Multilocus sequence typing (MLST) provides a higher-resolution phylogenetic framework for APEC epidemiology. MLST schemes targeting seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, recA) have been widely applied to characterize APEC population structure. Common sequence types (STs) associated with APEC include ST117, ST95, ST131, and ST23, with ST117 frequently linked to O78 strains [9]. Genomic characterization of APEC from Brazilian poultry revealed that ST117 and ST95 isolates carry distinct virulence gene profiles and prophage content, suggesting that MLST clonal complexes may differ in pathogenic potential [10]. The use of whole-genome sequencing (WGS) combined with MLST has enabled the identification of APEC as a potential marker organism for antimicrobial resistance surveillance in poultry production systems [9]. WGS data also facilitate the detection of plasmid replicon types and resistance genes, providing a comprehensive view of the genetic background of circulating strains.

The integration of serotyping and MLST data is essential for vaccine strain selection. Autogenous vaccines are typically formulated using the predominant serogroup(s) recovered from affected flocks, but MLST can reveal whether multiple clonal lineages are present, informing the need for multivalent formulations [1, 2]. For instance, a study evaluating the protective effects of Myrmecodia sp. extract against APEC infection in broilers used an O78 challenge strain, reflecting the clinical relevance of this serogroup [1]. Similarly, network pharmacology analysis of Sihuang Zhili Granules against APEC O78 challenge demonstrated that gut homeostasis modulation is a key mechanism of protection [2].

Vaccine Development Strategies

Vaccination against APEC in broilers aims to reduce the incidence and severity of colibacillosis, thereby decreasing antimicrobial use and improving flock uniformity. Two main vaccine types have been evaluated in commercial settings: autogenous bacterins and live-attenuated vaccines. Autogenous bacterins are inactivated whole-cell preparations derived from field isolates recovered from the target flock or region. They offer the advantage of antigenic matching to circulating strains but require timely production and may provide limited cross-protection against heterologous serogroups [7]. A comparative evaluation of outer membrane protein (OMP) and whole-cell antigen vaccines against APEC infection in broilers demonstrated that OMP-based vaccines induced stronger humoral and cell-mediated immune responses and conferred better protection against homologous challenge [7]. The OMP vaccine approach leverages conserved surface antigens that may elicit broader cross-protection compared to whole-cell bacterins.

Live-attenuated vaccines, typically generated by targeted deletion of virulence genes or metabolic pathways, can stimulate both mucosal and systemic immunity. Attenuation strategies have focused on deleting genes involved in aromatic amino acid biosynthesis (aroA), iron acquisition (iucD), or global regulators (lon, rpoS). Live vaccines have shown efficacy in reducing airsacculitis and mortality in experimental challenge models, but safety concerns regarding reversion to virulence and residual pathogenicity in immunocompromised birds remain [3, 4]. The use of artificial intelligence to identify novel antimicrobial peptides represents an alternative immunomodulatory approach, but these peptides are not vaccines per se; they are therapeutic agents that can be administered to reduce bacterial load [4].

The decision to implement autogenous bacterin versus live-attenuated vaccination depends on several factors including flock size, disease prevalence, production system, and regulatory approval. In many jurisdictions, autogenous vaccines are permitted under conditional licenses for use in specific flocks, whereas live-attenuated vaccines require more extensive safety and efficacy data for commercial registration. Recent advances in genomic surveillance and MLST have enabled more rational vaccine design by identifying conserved antigens across diverse APEC lineages [9]. For example, the OMP vaccine approach targets proteins such as OmpA, OmpC, and OmpF that are highly conserved among APEC strains, potentially providing cross-serogroup protection [7].

The following Mermaid diagram illustrates a decision workflow for APEC vaccine development in broiler flocks:

flowchart TD
    A[Colibacillosis outbreak in broiler flock], > B[Isolate APEC from lesions]
    B, > C[Serotyping and MLST characterization]
    C, > D{Identify predominant serogroup(s)}
    D, >|Single serogroup e.g., O78| E[Consider autogenous bacterin]
    D, >|Multiple serogroups| F[Consider multivalent autogenous or OMP vaccine]
    E, > G[Produce inactivated whole-cell bacterin]
    F, > H[Evaluate OMP vaccine candidates]
    G, > I[Field trial: efficacy and safety assessment]
    H, > I
    I, > J{Protection adequate?}
    J, >|Yes| K[Implement vaccination program]
    J, >|No| L[Re-isolate and characterize new strains]
    L, > B

Alternative and Adjunctive Strategies

Beyond vaccination, several alternative strategies have been investigated to control APEC in broilers. These include the use of probiotics, prebiotics, organic acids, and plant-derived compounds. Lactobacillus salivarius D5 has been shown to improve growth performance and immune function in broilers by reducing E. coli abundance and modulating gut microbiota composition [14]. Formic acid, herbal mixtures, and spirulina powder have been evaluated as antibiotic alternatives, with some formulations reducing cecal E. coli counts and improving blood biochemistry parameters [8]. The application of computer vision and artificial intelligence for early detection of disease-challenged broilers may enable timely intervention before colibacillosis becomes established [6, 13]. However, these approaches are adjunctive and do not replace the need for effective vaccination in high-risk flocks.

Conclusions

APEC remains a persistent challenge in broiler production due to the diversity of circulating serogroups and virulence gene repertoires, the emergence of multidrug-resistant strains, and the limitations of current vaccine strategies. The O78, O2, and O1 serogroups dominate clinical cases, and MLST has revealed that certain clonal complexes such as ST117 are globally distributed. Autogenous bacterins provide a rapid response option for specific outbreaks, while OMP-based vaccines and live-attenuated candidates offer potential for broader protection. Continued genomic surveillance, integration of serotyping and MLST data, and the development of cross-protective vaccine antigens are essential for sustainable APEC control. Future research should focus on identifying conserved immunogens that elicit robust mucosal and systemic immunity across diverse APEC lineages, as well as on the refinement of delivery systems suitable for mass application in broiler flocks.

References

1. Lisnanti EF, Lokapirnasari WP, Arif MAA, et al. Comparative effects of Myrmecodia sp. extract and infusion on organ function biomarkers, lipid metabolism, and meat lipid profile in avian pathogenic Escherichia coli-infected broiler chickens: Implications for sustainable poultry production within a One Health framework. Vet World. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42245456/

2. Guo Z, Wang X, Cai D, et al. Integrative analysis of 16S rRNA sequencing and network pharmacology suggests protective effects of Sihuang Zhili Granules against APEC O78 challenge through gut homeostasis-related changes. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42164768/

3. Ni W, Chen L, Chen H, et al. Genomic and pathogenic characterization of an extensively drug-resistant avian pathogenic Escherichia coli strain. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42147456/

4. Demirsoy E, Parkin TI, Mihalynuk SE, et al. Efficacy and safety evaluation of artificial intelligence-identified antimicrobial peptides targeting avian pathogenic Escherichia coli in broiler chickens. J Anim Sci Biotechnol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135842/

5. de Souza Campos MR, Dias TS, Gonçalves VD, et al. Clinical and non-clinical Escherichia coli from chickens reveal antimicrobial resistance patterns of one health concern. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42119341/

6. Soster P, Cardoen T, Carvalho CL, et al. Use of computer vision to automatically identify behaviors of healthy and disease-challenged male broiler chickens. Avian Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42117450/

7. Wani BM, Kamil SA, Shah SA, et al. Comparative evaluation of outer membrane protein and whole cell antigen vaccine against avian pathogen Escherichia coli infection in broiler chicken. Iran J Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42112298/

8. Ashour EA, Al-Ardhi SA, Elsayed DAA, et al. A comparative study of formic acid, herbal mixture and spirulina powder as antibiotic alternatives in broiler diets: Effects on growth, carcass traits, blood biochemistry and microbial load. Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42087212/

9. Gaonkar PP, Golden R, Santana-Pereira ALR, et al. Genomic characterization of avian pathogenic Escherichia coli and its potential as a marker organism for antimicrobial resistance. Appl Environ Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42080571/

10. Cadamuro RD, Pilati GVT, Elois MA, et al. Genome characterization of temperate bacteriophages and associated genetic features in avian pathogenic Escherichia coli from Brazilian poultry. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42071930/

11. Drag MH, Hvilsom C, Poulsen LL, et al. MethylSense: high accuracy machine learning-based diagnostics for Aspergillus fumigatus infection in chickens using host cell-free DNA methylation and Nanopore sequencing. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42037420/

12. ELTarabili RM, Abo Hashem ME, Ahmed MA, et al. Emergence of multidrug-resistant and virulent Escherichia coli with APEC-associated traits in broiler chickens from Ismailia, Egypt. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965406/

13. Soster P, Grzywalski T, Carvalho CL, et al. AI-based monitoring of broiler vocal repertoire dynamics reveals robust developmental and diurnal patterns but limited disease sensitivity. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41933532/

14. You Y, Zhu Y, Shi D, et al. Lactobacillus salivarius D5 improves growth performance and immune function in broilers by reducing Escherichia coli abundance and regulating the gut microbiota. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41905065/

15. Yongyod R, Eiamsam-Ang T, Kamolrat N, et al. Fluoroquinolone-resistant avian pathogenic Escherichia coli isolated from asymptomatic broiler chickens in a slaughterhouse in northern Thailand. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41901706/